UTOPIA SIS

UTOPIA aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

OUR FOCUS

  • DISEASE MODIFYING DRUGS
  • CROSS BORDER CON ARTIFICIAL INTELLIGENCE
  • MEDICAL DEVICES
  • DIAGNOSTIC TOOLS AND BIOMARKERS

OUR INVESTMENTS

  • Novavido Srl
  • PerFormS Srl 
  • Lighthouse Biotech Srl 
  • Drug Discovery and Clinic Srl
  • CaSRevolution Srl
  • T-One Therapeutics Srl

The promoting members

UTOPIA SIS S.p.A.

UTOPIA aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

What is a SIS

SIS is a Venture Capital vehicle aimed at investing in start-ups and unlisted SMEs and subject to a subsidized regime.

 

Our Focus

I

DISEASE MODIFYING DRUGS

I

CROSS BORDER CON ARTIFICIAL INTELLIGENCE

I

MEDICAL DEVICES

I

DIAGNOSTIC TOOLS AND BIOMARKERS